Cleared Traditional

K936016 - QUANTIKINE IVD ERYTHROPOIETIN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) (FDA 510(k) Clearance)

Jul 1994
Decision
215d
Days
Class 2
Risk

K936016 is an FDA 510(k) clearance for the QUANTIKINE IVD ERYTHROPOIETIN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA). This device is classified as a Assay, Erythropoietin (Class II - Special Controls, product code GGT).

Submitted by R&D Systems, Inc. (Minneapolis, US). The FDA issued a Cleared decision on July 19, 1994, 215 days after receiving the submission on December 16, 1993.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.7250.

Submission Details

510(k) Number K936016 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 16, 1993
Decision Date July 19, 1994
Days to Decision 215 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code GGT — Assay, Erythropoietin
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.7250